WC
TEVA icon

Whitnell & Co’s Teva Pharmaceuticals TEVA Stock Holding History

Whitnell & Co’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-95
Closed -$2K – 340
2018
Q2 		$2K Hold
95
– – ﹤0.01% 330
2018
Q1 		$2K Hold
95
– – ﹤0.01% 363
2017
Q4 		$2K Buy
+95
New +$1.43K ﹤0.01% 323
2017
Q3 		– Sell
-500
Closed -$17K – 236
2017
Q2 		$17K Sell
500
-28,403
-98% -$879K 0.01% 204
2017
Q1 		$927K Sell
28,903
-707
-2% -$24.1K 0.42% 67
2016
Q4 		$1.07M Sell
29,610
-1,218
-4% -$48.6K 0.5% 63
2016
Q3 		$1.42M Sell
30,828
-1,224
-4% -$63.9K 0.48% 55
2016
Q2 		$1.61M Sell
32,052
-1
-0% -$53 0.52% 54
2016
Q1 		$1.72M Sell
32,053
-538
-2% -$31.6K 0.64% 49
2015
Q4 		$2.14M Sell
32,591
-200
-0.6% -$12.4K 0.81% 40
2015
Q3 		$1.85M Buy
32,791
+1,488
+5% +$96.5K 0.73% 41
2015
Q2 		$1.85M Sell
31,303
-75
-0.2% -$4.63K 0.67% 44
2015
Q1 		$1.96M Sell
31,378
-450
-1% -$26.2K 0.73% 40
2014
Q4 		$1.83M Buy
31,828
+350
+1% +$19.5K 0.69% 43
2014
Q3 		$1.69M Sell
31,478
-2,950
-9% -$156K 0.67% 40
2014
Q2 		$1.8M Sell
34,428
-400
-1% -$20.4K 0.83% 38
2014
Q1 		$1.84M Sell
34,828
-375
-1% -$17.3K 0.86% 37
2013
Q4 		$1.41M Sell
35,203
-2,375
-6% -$93.5K 0.65% 47
2013
Q3 		$1.42M Sell
37,578
-1,450
-4% -$56.6K 0.7% 45
2013
Q2 		$1.53M Buy
+39,028
New +$1.52M 0.76% 38

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Whitnell & Co's TEVA Position: Q3 2018 in Review

Whitnell & Co sold out of Teva Pharmaceuticals (TEVA) in Q3 2018, closing a stake of 95 shares — an estimated $2K sold.

Whitnell & Co first reported a position in TEVA in Q2 2013 and held it in 20 quarters. The position peaked at $2.14M in Q4 2015. 556 funds tracked by Wall St. Rank hold TEVA as of Q3 2018.

  • Whitnell & Co reported no remaining Teva Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Whitnell & Co sold 95 Teva Pharmaceuticals shares in Q3 2018, an estimated $2K.
  • Whitnell & Co first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 20 quarters.
  • Whitnell & Co's Teva Pharmaceuticals position peaked at $2.14M in Q4 2015.
  • 556 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2018.

Based on Whitnell & Co's 13F filing for Q3 2018, filed 23 Oct 2018.